Measles protection fades fast in infants. A new study presented at IDWeek found that most babies lose detectable measles antibodies by age 6 months — earlier than previously thought — raising urgent questions about whether the current MMR vaccination schedule needs a rethink amid the worst U.S. measles surge in decades.
Measles protection fades fast in infants
A new study presented at IDWeek found that most U.S. infants lose detectable measles-neutralizing antibodies by age 6 months — well before the currently recommended MMR vaccination window of 12–15 months. Researchers analyzed leftover samples from 92 mother-infant pairs and tracked antibody levels at birth, 2 months, and 6 months. The likely explanation: most moms today are vaccinated rather than naturally infected, meaning they pass fewer antibodies to their babies.
This comes at a critical moment: the U.S. has recorded 4,410 measles cases in 2026 — the largest surge this century — and may soon lose its measles elimination status, which it achieved in 2000.
By the Numbers
Why it matters: With maternal antibody protection disappearing sooner than expected, pediatricians may need to personalize vaccination timing — especially for infants in outbreak zones or high-risk settings. Researchers are now eyeing 9 months as a potential earlier vaccination target, in line with WHO recommendations for high-risk countries.
